Article
Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4.
All Scholarly Works
Document Type
Article, Peer-reviewed
Publication Date
5-1-2004
Abstract
BACKGROUND: Calcitriol lowers parathyroid hormone (PTH) levels in patients with chronic kidney disease (CKD) stages 3 and 4, but its use is limited by a low therapeutic index and concerns regarding hypercalcemia and acceleration of kidney disease. We eval
Publication ISSN
0272-6386
Citation Information
Am J Kidney Dis 2004 May;43(5):877-90.